Search Results - "Boasman, Kristian" :: K.UTB vyhledávací portál

Loading…

P1003: RUXOLITINIB AND MAGROLIMAB INCREASES CALRETICULIN IN MYELOFIBROSIS CD34+ CELLS IN VITRO. PROOF OF CONCEPT FOR COMBINATION THERAPY

by Rinaldi, Ciro, Boasman, Kristian, Simmonds, Matthew
Published in HemaSphere (08.08.2023)

Get full text

Journal Article

Loading…

Expression of CD47 and CALR in myeloproliferative neoplasms: Potential new therapeutical targets

by Rinaldi, Ciro Roberto, Boasman, Kristian, Simmonds, Matthew
Published in Journal of clinical oncology (01.06.2023)

Get full text

Journal Article

Loading…

Effects of ruxolitinib and magrolimab on calreticulin in myelofibrosis CD34+ cells in vitro: Proof of concept for combination therapy

by Rinaldi, Ciro Roberto, Boasman, Kristian, Simmonds, Matthew
Published in Journal of clinical oncology (01.06.2023)

Get full text

Journal Article

Loading…

Expression of CD47 and CALR in myeloproliferative neoplasms: Potential new therapeutical targets

by Rinaldi, Ciro Roberto, Boasman, Kristian, Simmonds, Matthew
Published in Journal of clinical oncology (01.06.2022)

Get full text

Journal Article

Loading…

Expression of CD47 and CALR in myeloproliferative neoplasms and myelodysplastic syndrome: Potential new therapeutical targets

by Rinaldi, Ciro Roberto, Boasman, Kristian, Simmonds, Matthew
Published in Journal of clinical oncology (20.05.2020)

Get full text

Journal Article

Loading…

Combination of Ruxolitinib and Magrolimab Significantly Increases Calreticulin Expression in Myelofibrosis CD34+ Cells in Vitro. Proof of Concept for Combination Therapy

by Boasman, Kristian, Simmonds, Matthew J, Rinaldi, Ciro R
Published in Blood (15.11.2022)

Get full text

Journal Article

Loading…

Expression of CD47 and Calr in Myeloproliferative Neoplasms: Potential New Therapeutical Targets

by Boasman, Kristian, Simmonds, Matthew J, Rinaldi, Ciro R
Published in Blood (23.11.2021)

Get full text

Journal Article

Loading…

Expression of CD47 and Calr in Myeloproliferative Neoplasms and Myelodysplastic Syndrome: Potential New Therapeutical Targets

by Boasman, Kristian, Simmonds, Matthew J, Rinaldi, Ciro R
Published in Blood (13.11.2019)

Get full text

Journal Article

Loading…

Effect of ruxolitinib and magrolimab on calreticulin in myelofibrosis CD34+ cells in vitro: Proof of concept for combination therapy

by Rinaldi, Ciro Roberto, Boasman, Kristian, Simmonds, Matthew
Published in JCO global oncology (01.08.2023)

Get full text

Journal Article

Loading…

CD47 but Not Calreticulin Is over Expressed in Patients with Myeloproliferative Neoplasms

by Boasman, Kristian, Simmonds, Matthew J, Rinaldi, Ciro R
Published in Blood (29.11.2018)

Get full text

Journal Article

Loading…

PU.1 and JDP2 expression in myelodysplastic syndromes to predict treatment response and leukemia transformation

by Boasman, Kristian, Simmonds, Matthew, Saunthararajah, Yogen, Rinaldi, Ciro Roberto
Published in Journal of clinical oncology (20.05.2018)

Get full text

Journal Article

Loading…

Elucidating the molecular mechanisms of CALR and CD47 in myelodysplastic syndromes, myeloproliferative neoplasms

by Boasman, Kristian
Year of Publication 2021

Get full text

Dissertation

Loading…

GATA‐1: A potential novel biomarker for the differentiation of essential thrombocythemia and myelofibrosis

by Lally, James, Boasman, Kristian, Brown, Lilia, Martinelli, Vincenzo, Cappuccio, Ilaria, Sovani, Vishaka, Marinaccio, Christian, Crispino, John D., Graham, Ciaren, Rinaldi, Ciro
Published in Journal of thrombosis and haemostasis (01.06.2019)

Get full text

Journal Article

Loading…

Using PU.1 and Jun dimerization protein 2 transcription factor expression in myelodysplastic syndromes to predict treatment response and leukaemia transformation

by Boasman, Kristian, Simmonds, Matthew James, Graham, Ciaren, Saunthararajah, Yogen, Rinaldi, Ciro Roberto
Published in Annals of hematology (01.06.2019)

Get full text

Journal Article